Cancer, Rethought

Premium

Studying cancer is an enormous undertaking. Many researchers spend their lives trying to understand the genetic origins of the disease in its many forms, and how to stop it in its tracks. While most concentrate their efforts on a specific type of cancer, there are others who have taken on an even more difficult task: studying all cancers at the same time to try to determine which mutations in the cancer genome actually affect human health, and which ones don't. It's a task too large for any one lab, says the Dana-Farber Cancer Institute's Rameen Beroukhim.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.